Skip to main content
. 2014 Winter;13(Suppl):151–160.

Figure 6.

Figure 6

Western blot analysis of the rhINF-β. Lane 1: Chromatine prestained protein ladder (SinaClon, Tehran, Iran), Lane 2: rhINF-β as positive control (ZiferonTM, Zist Daru Danesh, Tehran, Iran), Lane 3: rhINF-β as positive control (Betaseron®, Bayer HealthCare, Germany), Cell lysates were analyzed before IPTG addition (Lane 4) and 1-4 h after addition of 0.2 mM IPTG (Lanes 5-8). The additional band with molecular weight of 18 kDa in periplasmic fraction after induction corresponds to rhINF-β. The arrow indicates position of rhINF-β